NFKB1 and atherosclerosis: In addition, lncRNA SNHG16 could regulate NF-κB signaling pathway by binding hsa-miR-17-5p, and then affect proliferation and inflammatory response in atherosclerosis patients, which provide a potential target for treating AS (An et al., 2019).